Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
- Posted on March 31, 2026
- By CNBC
- 2 Views
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Centessa is one of several companies working on a new class of drugs to treat narcolepsy, a condition that makes it difficult for people to stay awake.
